JD-5037
JD-5037 is a potent and selective CB1 receptor antagonist with an IC50 of 1.5 nM, designed for peripheral restriction. It is a valuable research tool for investigating metabolic disorders, such as obesity and fatty liver disease, in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1392116-14-1
Product Name Alternative
Inhibitor, inhibit, JD5037, JD-5037, JD 5037, CannabinoidReceptor, Cannabinoid Receptor, CB1R, CB
Field of Research
Pharmacology & Drug Discovery
Purity
98.14% (May vary between batches)
Solubility
DMSO:240 mg/mL (419.21 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.49 mM)
Smiles
CC (C) [C@H] (\N=C (\NS (=O) (=O) c1ccc (Cl) cc1) N1C[C@@H] (C (=N1) c1ccc (Cl) cc1) c1ccccc1) C (N) =O
Molecular Formula
C27H27Cl2N5O3S
Molecular Weight
572.51
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
247944-ML750 100 µL
KLF1 (Kruppel-like Factor 1 (erythroid), EKLF) (MaxLight 750) discontinued
Sign In for Pricing
View Details 